Properties of monoclonal antibodies directed against hepatitis B virus polymerase protein

Journal of Virology

Volumn 73, Issue 5, 1999, Pages 4188-4196

  Zu Putlitz, Jasper ^a,d   Lanford, Robert E ^b   Carlson, Rolf I ^a   Notvall, Lena ^b   De La Monte, Suzanne M ^a   Wands, Jack R ^a,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b SOUTHWEST FOUNDATION FOR BIOMEDICAL RESEARCH   (United States)

^c BROWN UNIVERSITY   (United States)

^d UNIVERSITY OF FREIBURG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EPITOPE; MONOCLONAL ANTIBODY; RECOMBINANT PROTEIN; RIBONUCLEASE; RNA; RNA POLYMERASE; VIRUS DNA; VIRUS PROTEIN;

ANTIBODY SPECIFICITY; ARTICLE; CANCER CELL CULTURE; CONTROLLED STUDY; HEPATITIS B VIRUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; LIVER CELL CARCINOMA; NONHUMAN; PRIORITY JOURNAL; PROTEIN LOCALIZATION; VIRUS REPLICATION;

EID: 0032930740     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.73.5.4188-4196.1999     Document Type: Article

References (74)

1. Aye, T. T., A. Bartholomeusz, T. Shaw, S. Bowden, A. Breschkin, J. McMillan, P. Angus, and S. Locarnini. 1997. Hepatitis B virus polymerase mutations during antiviral therapy in a patient following liver transplantation. J. Hepatol. 26:1148-1153.
2. Bartenschlager, R., M. Junker-Niepmann, and H. Schaller. 1990. The P gene product of hepatitis B virus is required as a structural component for genomic RNA encapsidation. J. Virol. 64:5324-5332.
3. Bartenschlager, R., and H. Schaller. 1988. The amino-terminal domain of the hepadnaviral P-gene encodes the terminal protein (genome-linked protein) believed to prime reverse transcription. EMBO J. 7:4185-4192.
4. Bartenschlager, R., and H. Schaller. 1992. Hepadnaviral assembly is initiated by polymerase binding to the encapsidation signal in the viral RNA genome. EMBO J. 11:3413-3420.
5. Bosch, V., R. Bartenschlager, G. Radziwill, and H. Schaller. 1988. The duck hepatitis B virus P-gene codes for protein strongly associated with the 5′-end of the viral DNA minus strand. Virology 166:475-485.
6. Chang, L. J., J. Dienstag, D. Ganem, and H. Varmus. 1989. Detection of antibodies against hepatitis B virus polymerase antigen in hepatitis B virus-infected patients. Hepatology 10:332-335.
7. Chen, C., and H. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
8. Condreay, L. D., T. T. Wu, C. E. Aldrich, M. A. Delaney, J. Summers, C. Seeger, and W. S. Mason. 1992. Replication of DHBV genomes with mutations at the sites of initiation of minus- and plus-strand DNA synthesis. Virology 188:208-216.
9. Feitelson, M. A., I. Millman, G. D. Duncan, and B. S. Blumberg. 1988. Presence of antibodies to the polymerase gene product(s) of hepatitis B and woodchuck hepatitis virus in natural and experimental infections. J. Med. Virol. 24:121-136.
10. Gallbert, F., E. Mandart, F. Fitoussi, P. Tiollais, and P. Charnay. 1979. Nucleotide sequence of the hepatitis B virus genome (subtype ayw) cloned in E. coli. Nature 281:646-650.
11. Ganem, D., and H. E. Varmus. 1987. The molecular biology of the hepatitis B viruses. Annu. Rev. Biochem. 56:651-693.
12. Gargano, N., S. Biocca, A. Bradbury, and A. Cattaneo. 1996. Human recombinant antibody fragments neutralizing human immunodeficiency virus type 1 reverse transcriptase provide an experimental basis for the structural classification of the DNA polymerase family. J. Virol. 70:7706-7712.
13. Geissler, M., K. Tokushige, C. C. Chante, V. R Zurawski, Jr., and J. R. Wands. 1997. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 112:1307-1320. (Comment, 112:1410-1414.)
14. Geissler, M., K. Tokushige, C. C. Chante, V. R Zurawski, Jr., and J. R. Wands. 1997. Cellular and humoral immune response to hepatitis B virus structural proteins in mice after DNA-based immunization. Gastroenterology 112:1307-1320. (Comment, 112:1410-1414.)
15. Günther, S., N. Piwon, A. Iwanska, R. Schilling, H. Meisel, and H. Will. 1996. Type, prevalence, and significance of core promoter/enhancer II mutations in hepatitis B viruses from immunosuppressed patients with severe liver disease. J. Virol. 70:8318-8331.
16. Hamer, D. H. 1986. Metallothionein. Annu. Rev. Biochem. 55:913-951.
17. Harlow, E., and D. Lane. 1988. Antibodies. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
18. Heermann, K. H., U. Goldmann, W. Schwartz, T. Seyffarth, H. Baumgarten, and W. H. Gerlich. 1984. Large surface proteins of hepatitis B virus containing the pre-s sequence. J. Virol. 52:396-402.
19. Hirsch, R. C., J. E. Lavine, L. J. Chang, H. E. Varmus, and D. Ganem. 1990. Polymerase gene products of hepatitis B viruses are required for genomic RNA packaging as well as for reverse transcription. Nature 344:552-555.
20. Hirsch, R. C., D. D. Loeb, J. R. Pollack, and D. Ganem. 1991. cis-acting sequences required for encapsidation of duck hepatitis B virus pregenomic RNA. J. Virol. 65:3309-3316.
21. Hu, J., and C. Seeger. 1996. Hsp90 is required for the activity of a hepatitis B virus reverse transcriptase. Proc. Natl. Acad. Sci. USA 93:1060-1064.
22. Hu, J., D. O. Toft, and C. Seeger. 1997. Hepadnavirus assembly and reverse transcription require a multi-component chaperone complex which is incorporated into nucleocapsids. EMBO J. 16:59-68.
23. Junker-Niepmann, M., R. Bartenschlager, and H. Schaller. 1990. A short cis-acting sequence is required for hepatitis B virus pregenome encapsidation and sufficient for packaging of foreign RNA. EMBO J. 9:3389-3396.
24. Kann, M., A. Bischof, and W. H. Gerlich. 1997. In vitro model for the nuclear transport of the hepadnavirus genome. J. Virol. 71:1310-1316.
25. Kann, M., H. G. Kochel, A. Uy, and R. Thomssen. 1993. Diagnostic significance of antibodies to hepatitis B virus polymerase in acutely and chronically HBV-infected individuals. J. Med. Virol. 40:285-290.
26. Knaus, T., and M. Nassal. 1993. The encapsidation signal on the hepatitis B virus RNA pregenome forms a stem-loop structure that is critical for its function. Nucleic Acids Res. 21:3967-3975.
27. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227:680-685.
28. Lanford, R. E., and J. S. Butel. 1979. Antigenic relationship of SV40 early proteins to purified large T polypeptide. Virology 97:295-306.
29. Lanford, R. E., Y.-H. Kirn, H. Lee, L. Notvall, and B. Beames. 1999. Mapping of the hepatitis B virus reverse transcriptase TP and RT domains by transcomplementation for nucleotide priming and by protein-protein interaction. J. Virol. 73:1885-1893.
30. Lanford, R. E., L. Notvall, and B. Beames. 1995. Nucleotide priming and reverse transcriptase activity of hepatitis B virus polymerase expressed in insect cells. J. Virol. 69:4431-4439.
31. Lanford, R. E., L. Notvall, H. Lee, and B. Beames. 1997. Transcomplementation of nucleotide priming and reverse transcription between independently expressed TP and RT domains of the hepatitis B virus reverse transcriptase. J. Virol. 71:2996-3004.
32. Lanford, R. E. Unpublished data.
33. Levin, H. L. 1997. It's prime time for reverse transcriptase. Cell 88:5-8.
34. Lien, J.-M., C. E. Aldrich, and W. S. Mason. 1986. Evidence that a capped oligoribonucleotide is the primer for duck hepatitis B virus plus-strand DNA synthesis. J. Virol. 57:229-236.
35. Lien, J.-M., D. J. Petcu, C. E. Aldrich, and W. S. Mason. 1987. Initiation and termination of duck hepatitis B virus DNA synthesis during virus maturation. J. Virol. 61:3832-3840.
36. Ling, R., D. Mutimer, M. Ahmed, E. H. Boxall, E. Elias, G. M. Dusheiko, and T. J. Harrison. 1996. Selection of mutations in the hepatitis B virus polymerase during therapy of transplant recipients with lamivudine. Hepatology 24:711-713.
37. Loeb, D. D., R. C. Hirsch, and D. Ganem. 1991. Sequence-independent RNA cleavages generate the primers for plus strand DNA synthesis in hepatitis B viruses: implications for other reverse transcribing elements. EMBO J. 10: 3533-3540.
38. Maciejewski, J. P., F. F. Weichold, N. S. Young, A. Cara, D. Zella, M. S. Reitz, Jr., and R. C. Gallo. 1995. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:667-673. (Comment, 1:628-629.)
39. Maciejewski, J. P., F. F. Weichold, N. S. Young, A. Cara, D. Zella, M. S. Reitz, Jr., and R. C. Gallo. 1995. Intracellular expression of antibody fragments directed against HIV reverse transcriptase prevents HIV infection in vitro. Nat. Med. 1:667-673. (Comment, 1:628-629.)
40. McGarvey, M. J., R. D. Goldin, P. Karayiannis, and H. C. Thomas. 1996. The expression of hepatitis B virus polymerase in hepatocytes during chronic HBV infection. J. Viral Hepat. 3:67-73.
41. Molnar-Kimber, K. L., J. Summers, J. M. Taylor, and W. S. Mason. 1983. Protein covalently bound to minus-strand DNA intermediates of duck hepatitis B virus. J. Virol. 45:165-172.
42. Molnar-Kimber, K. L., J. W. Summers, and W. S. Mason. 1984. Mapping of the cohesive overlap of duck hepatitis B virus DNA and of the site of initiation of reverse transcription. J. Virol. 51:181-191.
43. Moradpour, D., B. Compagnon, B. E. Wilson, C. Nicolau, and J. R. Wands. 1995. Specific targeting of human hepatocellular carcinoma cells by immunoliposomes in vitro. Hepatology 22:1527-1537.
44. Nakabayashi, H., K. Taketa, K. Miyano, T. Yamane, and J. Sato. 1982. Growth of human hepatoma cell lines with differentiated functions in chemically defined medium. Cancer Res. 42:3858-3863.
45. Nassal, M., and A. Rieger. 1996. A bulged region of the hepatitis B virus RNA encapsidation signal contains the replication origin for discontinuous first-strand DNA synthesis. J. Virol. 70:2764-2773.
46. National Institutes of Health. NIH Image 1.60. National Institutes of Health, Bethesda, Md.
47. Pollack, J. R., and D. Ganem. 1993. An RNA stem-loop structure directs hepatitis B virus genomic RNA encapsidation. J. Virol. 67:3254-3263.
48. Radziwill, G., W. Tucker, and H. Schaller. 1990. Mutational analysis of the hepatitis B virus P gene product: domain structure and RNase H activity. J. Virol. 64:613-620.
49. Rehermann, B., P. Fowler, J. Sidney, J. Person, A. Redeker, M. Brown, B. Moss, A. Sette, and F. V. Chisari. 1995. The cytotoxic T lymphocyte response to multiple hepatitis B virus polymerase epitopes during and after acute viral hepatitis. J. Exp. Med. 181:1047-1058.
50. Rondon, I. J., and W. A. Marasco. 1997. Intracellular antibodies (intrabodies) for gene therapy of infectious diseases. Annu. Rev. Microbiol. 51:257-283.
51. Seeger, C., D. Gunem, and H. E. Varmus. 1986. Biochemical and genetic evidence for the hepatitis B virus replication strategy. Science 232:477-484.
52. Seeger, C., and J. Maragos. 1990. Identification and characterization of the woodchuck hepatitis virus origin of DNA replication. J. Virol. 64:16-23.
53. Seeger, C., and J. Maragos. 1991. Identification of a signal necessary for initiation of reverse transcription of the hepadnavirus genome. J. Virol. 65:5190-5195.
54. Seeger, C., and J. Maragos. 1989. Molecular analysis of the function of direct repeats and a polypurine tract for plus-strand DNA priming in woodchuck hepatitis virus. J. Virol. 63:1907-1915.
55. Seifer, M., and D. N. Standring. 1993. Recombinant human hepatitis B virus reverse transcriptase is active in the absence of the nucleocapsid or the viral replication origin, DR1. J. Virol. 67:4513-4520.
56. Selden, R. F., K. B. Howie, M. E. Rowe, H. M. Goodman, and D. D. Moore. 1986. Human growth hormone as a reporter gene in regulation studies employing transient gene expression. Mol. Cell. Biol. 6:3173-3179.
57. Sells, M. A., M. L. Chen, and G. Acs. 1987. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc. Natl. Acad. Sci. USA 84:1005-1009.
58. Shaheen, F., L. Duan, M. Zhu, O. Bagasra, and R. J. Pomerantz. 1996. Targeting human immunodeficiency virus type 1 reverse transcriptase by intracellular expression of single-chain variable fragments to inhibit early stages of the viral life cycle. J. Virol. 70:3392-3400.
59. Staprans, S., D. D. Loeb, and D. Ganem. 1991. Mutations affecting hepadnavirus plus-strand DNA synthesis dissociate primer cleavage from translocation and reveal the origin of linear viral DNA. J. Virol. 65:1255-1262.
60. Stemler, M., J. Hess, R. Braun, H. Will, and C. H. Schroder. 1988. Serological evidence for expression of the polymerase gene of human hepatitis B virus in vivo. J. Gen. Virol. 69:689-693.
61. Summers, J., and W. S. Mason. 1982. Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate. Cell 29:403-415.
62. Tavis, J. E., and D. Ganem. 1993. Expression of functional hepatitis B virus polymerase in yeast reveals it to be the sole viral protein required for correct initiation of reverse transcription. Proc. Natl. Acad. Sci. USA 90:4107-4111.
63. Tavis, J. E., S. Perri, and D. Ganem. 1994. Hepadnavirus reverse transcription initiates within the stem-loop of the RNA packaging signal and employs a novel strand transfer. J. Virol. 68:3536-3543.
64. Tipples, G. A., M. M. Ma, K. P. Fischer, V. G. Bain, N. M. Kneteman, and D. L. Tyrrell. 1996. Mutation in HBV RNA-dependent DNA polymerase confers resistance to lamivudine in vivo. Hepatology 24:714-717.
65. Wands, J. R., and V. R. Zurawski, Jr. 1981. High affinity monoclonal antibodies to hepatitis B surface antigen (HBsAg) produced by somatic cell hybrids. Gastroenterology 80:225-232.
66. Wang, G. H., and C. Seeger. 1993. Novel mechanism for reverse transcription in hepatitis B viruses. J. Virol. 67:6507-6512.
67. Wang, G. H., and C. Seeger. 1992. The reverse transcriptase of hepatitis B virus acts as a protein primer for viral DNA synthesis. Cell 71:663-670.
68. Ward, G. A., C. K. Stover, B. Moss, and T. R. Fuerst. 1995. Stringent chemical and thermal regulation of recombinant gene expression by vaccinia virus vectors in mammalian cells. Proc. Natl. Acad. Sci. USA 92:6773-6777.
69. Weimer, T., F. Schodel, M. C. Jung, G. R. Pape, A. Alberti, G. Fattovich, H. Beljaars, P. M. van Eerd, and H. Will. 1990. Antibodies to the RNase H domain of hepatitis B virus P protein are associated with ongoing viral replication. J. Virol. 64:5665-5668.
70. Weimer, T., K. Weimer, Z. X. Tu, M. C. Jung, G. R Pape, and H. Will. 1989. Immunogenicity of human hepatitis B virus P-gene derived proteins. J. Immunol. 143:3750-3756.
71. Will, H., W. Reiser, T. Weimer, E. Pfaff, M. Buscher, R. Sprengel, R. Cattaneo, and H. Schaller. 1987. Replication strategy of human hepatitis B virus. J. Virol. 61:904-911.
72. Wu, T. T., L. Coates, C. E. Aldrich, J. Summers, and W. S. Mason. 1990. In hepatocytes infected with duck hepatitis B virus, the template for viral RNA synthesis is amplified by an intracellular pathway. Virology 175:255-261.
73. Yuki, N., N. Hayashi, A. Kasahara, K. Katayama, K. Ueda, H. Fusamoto, and T. Kamada. 1990. Detection of antibodies against the polymerase gene product in hepatitis B virus infection. Hepatology 12:193-198.
74. zu Putlitz, J., J. Encke, and J. R. Wands. 1998. The use of antisense and other molecular approaches to therapy of chronic viral hepatitis. Viral Hepatitis Rev. 4:207-227.